Andres Tellez
Corporate Officer/Principal presso Johnson & Johnson Innovation - JJDC, Inc.
Provenienza dei contatti di primo grado di Andres Tellez
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.
23
| Subsidiary | Investment Managers | 23 |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA.
2
| Holding Company | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Andres Tellez tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Director/Board Member | |
University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Drexel University College of Medicine | College/University | Doctorate Degree Doctorate Degree | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Visus Therapeutics, Inc.
Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member Director/Board Member | |
University of California | College/University | Doctorate Degree Undergraduate Degree | |
Ovuline, Inc.
Ovuline, Inc. Information Technology ServicesTechnology Services Ovuline, Inc. designs and develops applications for women?s health. It designed two applications, Ovia Fertility and Ovia Pregnancy, to track women?s fertility and pregnancy and also provide users with a feedback loop for their symptoms. The company was founded by Alex Baron and Paris Wallace in June, 2012 and is headquartered in Boston, MA. | Information Technology Services | Director/Board Member Director/Board Member | |
The Hebrew University of Jerusalem | College/University | Undergraduate Degree Undergraduate Degree | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, is the only National Cancer Institute-designated comprehensive cancer center in New Jersey. Rutgers Cancer Institute has locations in New Brunswick and at University Hospital in Newark, as well as through RWJBarnabas Health facilities. The institute offers advanced cancer treatment options, including bone marrow transplantation, proton therapy, CAR T-cell therapy, and complex surgical procedures. Patients have access to cutting-edge therapies such as precision medicine and immunotherapy, many of which are not widely available. The top cancer researchers and clinicians throughout the state collaborate to apply the latest technologies, therapies, and approaches to improve cancer diagnosis and treatment. | Hospital/Nursing Management | Director/Board Member | |
Lake Forest College | College/University | Undergraduate Degree | |
Robert Wood Johnson Medical School | College/University | Corporate Officer/Principal | |
University of Medicine & Dentistry of New Jersey | College/University | Corporate Officer/Principal | |
Yale Cancer Center
Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Hospital/Nursing Management | Director/Board Member | |
Research!America
Research!America Miscellaneous Commercial ServicesCommercial Services Research!America is a lobbying firm. The non-profit company is based in Alexandria, VA. The CEO of the company is Mary Woolley. | Miscellaneous Commercial Services | Director/Board Member | |
Yale School of Medicine | College/University | Corporate Officer/Principal | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Treasurer | |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The company is based in Raritan, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Vascular Pharmaceuticals, Inc.
Vascular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vascular Pharmaceuticals, Inc. develops and commercializes therapeutics for the treatment of diabetics. It provides new treatment options to individuals living with diabetic complications such as nephropathy. The company was founded by David R. Clemmons and Laura Maile in 2005 and is headquartered in Research Triangle Park, NC. | Pharmaceuticals: Major | Director/Board Member | |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Private Equity Analyst | |
University of Aberdeen | College/University | Doctorate Degree | |
Nottingham Trent University | College/University | Undergraduate Degree | |
RainDance Technologies, Inc.
RainDance Technologies, Inc. Medical SpecialtiesHealth Technology RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Analyst | |
Florida State University | College/University | Undergraduate Degree | |
The University of Colorado | College/University | Doctorate Degree | |
Medtronic CardioVascular
Medtronic CardioVascular Medical SpecialtiesHealth Technology Medtronic CardioVascular manufactures medical devices. Its products include dru-eluting stents, guide catheters, guidewires and balloon diagnostic catheters to treat diabetes, heart disease, neurological disorders and vascular illnesses. The company is headquartered in Santa Rosa, CA. | Medical Specialties | Corporate Officer/Principal | |
INTEL CORPORATION | Semiconductors | Chief Tech/Sci/R&D Officer | |
New England Venture Capital Association, Inc.
New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Pivot Health Technologies, Inc.
Pivot Health Technologies, Inc. Packaged SoftwareTechnology Services Pivot Health Technologies, Inc. provides smoking digital health technology solutions. It offers Pivot, a personal sensor and smoking cessation program that uses an FDA-cleared mobile breath sensor, consumer-grade mobile app, behavioral science, and personal coaching. The company was founded by David S. Utley and is headquartered in Redwood City, CA. | Packaged Software | Director/Board Member | |
Morgan Stanley Expansion Capital
Morgan Stanley Expansion Capital Investment ManagersFinance Morgan Stanley Expansion Capital (Morgan Stanley Expansion Capital) is a private equity firm, a subsidiary of Morgan Stanley Investment Management Merchant Banking founded in 1986. The firm is headquartered in Los Angeles, California. | Investment Managers | Consultant / Advisor | |
Weizmann Institute of Science | College/University | Graduate Degree | |
A2i Therapeutics Ltd.
A2i Therapeutics Ltd. Investment ManagersFinance A2i Therapeutics Ltd. is an Israeli AI-based drug-design company that aims to develop novel therapeutic modulators of the protein ADAR1, a key element of the innate immune system. The company is a joint venture of the FutuRx Incubator and Atomwise, utilizing the AtomNet® AI platform and FutuRx’s technology to translate extraordinary technologies to life-changing therapies. | Investment Managers | Director/Board Member | |
Protekt Therapeutics Ltd.
Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Protekt Therapeutics Ltd. operates as a biopharmaceutical company. The firm develop a drug for enhancing the long-term memory of those suffering from mild cognitive impairment. The company is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 41 |
Israele | 7 |
Regno Unito | 4 |
Svizzera | 2 |
Settori
Health Technology | 21 |
Consumer Services | 16 |
Finance | 7 |
Commercial Services | 5 |
Technology Services | 3 |
Posizioni
Director/Board Member | 116 |
Corporate Officer/Principal | 44 |
Private Equity Investor | 33 |
Undergraduate Degree | 18 |
Doctorate Degree | 14 |
Contatti più connessi
Insiders | |
---|---|
Asish Xavier | 33 |
Fiona MacLaughlin | 22 |
V. Kadhiresan | 21 |
Zeev Zehavi | 18 |
Marian Nakada | 16 |
William Hait | 13 |
Stacy Feld | 13 |
Lior Teitelbaum | 11 |
Noam Krantz | 10 |
Tamir Meiri | 10 |
Rosana Kapeller-Libermann | 10 |
Christopher Bowden | 9 |
Asha Nayak | 9 |
Debi Watson | 9 |
Anurag Mehta | 8 |
- Borsa valori
- Insiders
- Andres Tellez
- Connessioni Società